Kawasaki disease in an infant following immunisation with hepatitis B vaccine

Dan Miron1, Daniel Fink, Philip J Hashkes

  • 1HaEmek Medical Center, Afula, Technion Medical School, Haifa, Israel.

Clinical Rheumatology
|December 17, 2003
PubMed

Insights

Hepatitis B vaccination in infants may rarely be linked to Kawasaki disease, a serious inflammatory condition. Further research is needed to understand this potential association and ensure vaccine safety.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Hepatitis B vaccination is a standard preventative measure in infants.
  • Vasculitis, including Kawasaki disease, is a known but rare complication associated with hepatitis B vaccination in adults.

Observation:

  • A 35-day-old infant developed symptoms consistent with Kawasaki disease.
  • The infant received his second dose of the hepatitis B vaccine one day prior to symptom onset.

Findings:

  • This case presents a potential, albeit extremely rare, association between hepatitis B vaccination and Kawasaki disease in an infant.
  • The temporal relationship suggests a possible adverse reaction that warrants further investigation.

Implications:

  • Healthcare providers should be aware of this rare potential side effect.
  • Further studies are crucial to confirm or refute this association and guide vaccination protocols.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations01:51

Vaccinations

Overview
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...